Washington, DC 20006-5349
HELPLINE
This week, the Mesothelioma Applied Research Foundation, the leading organization funding mesothelioma research and providing patient services, announced the election of new Co-Chairs of its Board of Directors.
Read more in our press release here http://www.prweb.com/releases/2011/1/prweb8090988.htm.
The Mesothelioma Applied Research Foundation is excited to announce its latest research grant recipients, awarding a total of $300,000. This brings the Foundation’s total funding
At the Mesothelioma Applied Research Foundation, we are guided by the three core pillars that define our purpose: funding groundbreaking research, providing essential treatment support
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
